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ABSTRACT 
Background: Deciding whether or not to have breast reconstruction following breast cancer 
diagnosis is a complex decision process. This randomized controlled trial assessed the impact 
of an online decision aid (BRECONDA - Breast RECONstruction Decision Aid) on breast 
reconstruction decision-making. Methods: Women (N=222) diagnosed with breast cancer or 
ductal carcinoma in situ (DCIS), and eligible for reconstruction following mastectomy, 
completed an online Baseline questionnaire. They were then randomly assigned to receive 
either standard online information about breast reconstruction (control) or standard 
information plus access to BRECONDA (intervention). Participants then completed 
questionnaires at 1- and 6-months post-randomization. The primary outcome was 
participants’ decisional conflict 1-month after exposure to the intervention. Secondary 
outcomes included decisional conflict at 6-months, satisfaction with information at 1- and 6-
months, and 6-month decisional regret. Results: Linear mixed-model analyses revealed that 
1-month decisional conflict was significantly lower in the intervention group (27.18) 
compared with the control (35.5). This difference was also sustained at the 6-month follow-
up. Intervention participants reported greater satisfaction with information at 1- and 6-month 
follow-up, and there was a non-significant trend for lower decisional regret in the 
Intervention group at 6-month follow-up. Intervention participants’ ratings for BRECONDA 
demonstrated high user acceptability and overall satisfaction. Conclusions: Women who 
accessed BRECONDA benefited by experiencing significantly less decisional conflict and 
being more satisfied with information regarding the reconstruction decisional process, than 
women receiving standard care alone. These findings support the efficacy of BRECONDA in 
helping women to arrive at their breast reconstruction decision.  
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Approximately 800,000 women in the Western world are diagnosed with breast cancer each 
year
1-4
, with 30-40% requiring mastectomy, entailing surgical removal of breast tissue
5
.  
These women face the challenging decision of whether, how, and when to reconstruct their 
breast following mastectomy. Decisions are complicated by the many available 
reconstruction options, the need to consider advantages and complications of each option, as 
well as the potential influence of treatment (i.e., radiation and chemotherapy) on 
reconstruction outcomes
6
. Decisions regarding immediate reconstruction must often be made 
within days of diagnosis
6
, although women may opt for delayed reconstruction any time after 
their mastectomy. The decision about breast reconstruction is influenced by a multitude of 
factors, including access to breast reconstruction surgery, and understanding of the required 
surgeries and potential surgical benefits. Personal values play a key role in this decision, and 
so it is important that patients have access to appropriate information and are supported so 
that they can carefully weigh up all options and express their true treatment preferences
7
. A 
key focus for health professionals is to facilitate effective decision making, ensuring that 
women make informed choices that reflect personal values, rather than specific decisions 
made for or against having reconstructive surgery.  
The responsibility and uncertainty associated with making the reconstruction decision 
can be overwhelming and burdensome, leading to poor psychosocial outcomes
6
. Decisional 
conflict is commonly experienced, reflecting indecision characterized by feeling uncertain, 
delaying decision making, vacillation between choices and questioning of values and beliefs
8
. 
As breast reconstruction can be performed immediately following mastectomy, or as a 
delayed procedure, women may experience decisional conflict both prior to initial surgery 
and at a later date
8
. Moreover, in the longer term women may experience decisional regret 
regarding the reconstruction decision. Importantly, decisional regret has been documented in 
both women who have opted for, and against, breast reconstruction, further emphasizing the 
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importance of the decisional process in arriving at a final decision about reconstructive 
surgery
9,10
. 
Decision aids are educational resources designed to provide information and facilitate 
treatment decision-making, taking into account individual values and preferences
11,12
. Within 
the breast cancer context generally, tools for assisting women in decisions about 
mammographic screening, treatment options and genetic risk assessment, have improved 
knowledge
13-15
, increased satisfaction with information
11
, clarified personal values and 
preferences
16
, facilitated readiness to make surgical decisions
7
, and reduced decisional 
conflict and regret
13,14,17-19
. Computer-based decision aids have similar benefits to paper-
based versions, with greater potential reach through web-based applications
20
.  
While some decision tools outline breast reconstruction options
7,8,21
, they are limited 
as they do not specifically focus on decisional complexities. Furthermore, while other 
decision-type tools (e.g., option grids) can be effective 
22
, they do not have the scope to detail 
all information relevant to reconstruction decision-making, and do not incorporate 
components unique to decision aids (e.g., values clarification exercises). Thus, existing 
decision tools are not sufficient to facilitate informed decision making about reconstruction. 
BRECONDA (Breast RECONstruction Decision Aid; available at www.breconda.org, for 
access please contact Corresponding Author) is a rigorously-developed, interactive web-
based intervention to facilitate decision making regarding breast reconstruction
23
. Preliminary 
testing indicated high user-acceptability and ease-of-use, enabling women to feel secure in 
their reconstruction decisions and better prepared for surgical consultations.  
We conducted a randomized controlled trial (RCT) to evaluate the effectiveness of 
BRECONDA among women who were considering breast reconstruction following 
mastectomy. The primary outcome was decisional conflict one month following 
randomization. The decision-making process is multi-faceted
24
, hence we also assessed 
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satisfaction with reconstruction-related information and decisional regret as secondary 
outcomes in this study
8,25
. We hypothesized that women who accessed BRECONDA would 
report reduced decisional conflict at one-month follow-up, compared with women receiving 
standard care alone. Secondary hypotheses were that women provided with BRECONDA 
would report reduced decisional conflict and decisional regret at 6-months, and greater 
satisfaction with information at 1- and 6-months, compared to women receiving standard 
care.  User acceptability of the BRECONDA intervention was also assessed at 6-months.  
METHODS 
Study Design and Procedures   
Eligible women were diagnosed with breast cancer or ductal carcinoma in situ (DCIS); 
recommended to undergo/had already undergone a mastectomy; over 18 years of age; English 
language competent for reading and writing; had no prior breast surgery (e.g., reconstruction 
or augmentation); and, had internet access.  
Participants (N=222) were recruited between December 2011 and August 2013 from    
breast centers (n=76) (six metropolitan-based breast clinics - 3 Public, 3 Private; two regional 
private breast clinics), and nationwide community-based breast cancer consumer 
organizations (n=146). Figure 1 describes the flow of participants through the study. Clinic 
staff gave eligible women an invitation containing study information and the web address at 
which study registration and consent took place, and emailed invitations were sent to 
consumer organization members with a direct link to the study web address.  
After registering and consenting at the study website, participants completed an online 
baseline questionnaire and were then automatically randomized to the Intervention or Control 
condition using a computer-generated random number sequence from Statistical Analysis 
Software (Cary, NC: SAS Institute Inc.). Clinic and surgical staff were blind to condition 
assignment. Additional online questionnaires were completed at 1- and 6-months post-
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baseline.  Ethical approval for this trial was granted by the relevant institutional human 
research ethics committee. This trial was registered with the Australian New Zealand Clinical 
Trials Registry: ACTRN-12609000363280.  
Intervention Condition 
Participants allocated to the Intervention condition received access to BRECONDA for the 6-
month duration of study enrollment, and the standard information provided to Control 
participants. BRECONDA is organized in a menu-driven modular format, with each module 
addressing an identified area of need for women considering breast reconstruction. It is self-
paced and includes core screens providing basic information, plus optional components with 
more detailed material allowing users to select the extent of information accessed, to match 
their personal information processing style
26
. It is estimated that the average user would take 
45 minutes to review all sections of the website.  BRECONDA includes breast reconstruction-
related information, strategies for managing emotions related to the reconstruction decision, 
values clarification components and video segments detailing other patient’s experiences. 
Table 1 details the components of BRECONDA, and Figures 2-4 illustrate these components. 
Other details pertaining to BRECONDA are described in detail elsewhere
23
.  
Control Condition 
Participants in the Control group received online access to information from an excerpt of a 
publicly available booklet “Guide for Women with Early Breast Cancer”27 including basic 
information about breast surgery and reconstruction, but not  components unique to 
BRECONDA (i.e., video interviews with patients/surgeons, values clarification exercises).  
The booklet was available for all study participants (irrespective of condition) throughout 
study duration. Participants were not instructed to avoid other information sources. 
Study Outcome Measures 
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The primary outcome for this study was decisional conflict at 1-month post-randomization. 
Secondary outcomes included decisional conflict (6-months), satisfaction with 
reconstruction-related information (1- and 6-months), and decisional regret (6-months).          
  The 16-item Decisional Conflict Scale (DCS)
28,29
 assessed the extent to which an 
individual experienced conflict regarding the reconstruction decision (α range: .83 - .96). 
Items were summed, divided by 16 and multiplied by 25. Consistent with the scale’s user 
manual, scores lower than 25 were associated with implementing a breast reconstruction 
decision; scores exceeding 37.5 were translated to mean greater decision delay and feeling 
unsure about one’s reconstruction decision. Satisfaction with reconstruction-related 
information was assessed by a 5-item scale adapted from measures used in previous 
research
30,31
, with higher scores indicating greater satisfaction (α = .82). Regret was assessed 
by the 5-item Decision Regret Scale (α = .82)32. Items were summed and averaged to 
calculate a final score, with higher scores indicating greater regret. User acceptability of 
BRECONDA was assessed (at 6-month follow-up, by intervention participants) using six 
statements similar to those used in previous research
33
, rated on a 5-point Likert-type scale 
(0-Not at all to 4-Very much so), with higher scores indicating greater user acceptability (α 
=.93). 
 Demographics and medical history (age, education, marital status, country of birth, 
cancer stage, time since diagnosis, and, current treatment-, mastectomy- and reconstruction-
status) were measured for sample description and potential use as covariates. Extent of 
reconstruction information received from a doctor/surgeon prior to study entry,  and 
depressive symptoms  DASS-21
34
 and  perceived social support  SSQ-6
35
 at study entry, were 
measured as these may confound the impact of a decisional support intervention
36,37
. 
Statistical Analysis 
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Baseline demographic, medical characteristics, and depression and social support, were 
compared across conditions by conducting t-tests and 2 tests. Maximum-likelihood linear 
mixed models tested the effect of the intervention on the outcomes. Confounding effects of 
several variables were controlled for including age, education, time since diagnosis, 
mastectomy status at baseline, recent treatment received, reconstruction status at each follow-
up, baseline depression and social support, and prior receipt of reconstruction-related 
information from a breast surgeon or physician. Fixed effects included time, intervention 
group and their interaction, baseline outcome levels, and identified confounding variables. 
The parameters of primary interest were the fixed effect interaction terms between conditions 
and times, describing whether the participants in the two conditions changed differently in 
decisional conflict across the observation period, as well as the planned contrasts comparing 
post-randomization group means of all outcomes. Random effects for a participant-specific 
random intercept accounted for within-participant correlation. Cohen’s d was used as a 
measure of effect size for each outcome. All analyses used the standard alpha level of 0.05 
and were carried out using SPSS version 21. Sample size was calculated to detect an effect 
size of 0.3 in decisional conflict (two-sided alpha=.05 and power ≥ 80%). The intended final 
sample was 80 per group.  We allowed for an anticipated dropout rate of 30%, which is 
common in internet-based intervention research 
38,39
. Accordingly, we planned to recruit 226 
women into the study.   
RESULTS 
Forty-five women had undergone bilateral mastectomy for contralateral primaries (no women 
had bilateral prophylactic mastectomy). At baseline, there were no differences between the 
two conditions in demographic characteristics (Table 2). There were also no differences in 
dropout rates between assigned conditions on baseline characteristics (χ2=.045, P=.83). 
Women who dropped out reported a larger social network than study participants (Social 
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SupportNumber: Intervention 6.79 v Control 5.19; t=2.36, P=.03).  There was no difference in 
reconstruction rate between Intervention and Control groups at 1-month (Intervention 14 v 
Control 17; 2 =.688, P=.701) with most women (75%) undergoing implant reconstruction. 
Of all reconstructions, 62% were immediate (80% of which were implants) and 38% were 
delayed procedures. At 6-months there were also no group differences in reconstruction rate 
(Intervention 16 v Control 19; 2 =.417, P=.451) with 64% of women undergoing implant, 
21% Transverse Rectus Abdominis Myocutaneous flap, 9% Deep Inferior Epigastric 
Perforator flap, and 6% Latissimus Dorsi flap, surgery. Of all reconstructions, 46% were 
immediate (85% of which were implants) and 54% were delayed procedures. The median 
time since mastectomy for women considering delayed reconstruction was 25 months (range 
1 week to 29 years). Source of recruitment, mastectomy status at time of recruitment, and 
reconstruction status at follow-up, had no impact on the effect of the intervention on any of 
the outcomes assessed.  
Intervention Effects on Decisional Conflict, Satisfaction with Information and 
Decisional Regret 
Overall, the interaction of condition by time was significant F=4.01, P=.019 for decisional 
conflict, which decreased over time for both conditions, but at a greater rate for Intervention 
participants. Decisional conflict planned contrasts results are displayed in Table 3, Figure 2 
and Figure 3 (adjusted means). After adjusting for baseline decisional conflict, and 
covariates, mean decisional conflict was significantly lower in the BRECONDA group at 1-
month follow-up. Secondary analyses indicated that this difference in decisional conflict 
between conditions was sustained at the 6-month  follow-up.  
Analysis of secondary outcomes also indicated a significant difference in satisfaction 
with information between groups at 1- and 6-months F=7.41, P=.007 (after adjusting for 
covariates), with satisfaction greater in the BRECONDA group at both timepoints (Table 3, 
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Figure 2 and Figure 3). At 6-months, BRECONDA participants demonstrated lower regret 
(non-significant trend) compared with Control participants F=3.46, P=.065 (Table 3).  
User Satisfaction  
Intervention participants’ ratings of BRECONDA demonstrated high user acceptability with 
overall high satisfaction (M =2.89, SD=.68). They reported that the website provided a 
balanced view (M =2.94, SD=.76), was useful (M=2.79 SD=.92) and easy to use (M=3.05, 
SD=.88), contained sufficient information (M=2.88, SD=.80), and helped them to clarify their 
thoughts about reconstruction (M=2.50, SD=.81). 
DISCUSSION 
This study assessed the impact of BRECONDA in women with breast cancer who were 
eligible for breast reconstruction. Of primary interest was the effect on decisional conflict at 
1-month post-randomization. As predicted, participants who received BRECONDA 
experienced significantly less decisional conflict, compared with control participants. At 
baseline, both participant groups experienced moderate levels of decisional conflict. 
Following provision of BRECONDA, decisional conflict at 1-month decreased for 
intervention participants to levels consistent with having implemented, or made, the decision, 
whereas controls reported levels of decisional conflict reflecting indecision and decisional 
delay
29
. Even by 6-months the control group still experienced decisional conflict scores 
reflecting indecision (>31), whereas the intervention participants retained the benefits of low 
decisional conflict that were evident at 1-month. This finding is important, given that higher 
levels of decisional conflict have been associated with greater depressive symptomatology in 
the long-term
40
. Thus, the changes in decisional conflict reported are both statistically and 
clinically significant. For BRECONDA participants, their reduction in decisional conflict was 
both greater, and at a faster rate, than for individuals assigned to the Control group. This 
suggests that BRECONDA helped women to feel informed, have clarity about their 
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reconstruction-related values, feel supported in the decision-making process, and feel certain 
and satisfied about their decision. The reduction in decisional conflict represents a 
statistically and clinically meaningful reduction, having gone from a state of indecision to 
decision completion or implementation
29
. These findings are consistent with previous 
research, which demonstrated reductions in decisional conflict in patients who accessed 
general breast surgery-related decision aids 
13,14,17-19,41
, and indicate the potential for 
BRECONDA to diminish feelings of decisional conflict amongst women faced with the 
option of breast reconstruction. As such, these results suggest that the BRECONDA 
intervention is a valuable adjunct to medical consultations, and can be used by surgeons 
according to their unique surgical expertise and preferences. 
 
Our results also demonstrated that, compared with control participants, those who accessed 
BRECONDA reported greater satisfaction with breast reconstruction information. This is 
consistent with previous research, where decision aids in the breast cancer context increase 
satisfaction with information received
11
.  It is possible that women allocated to BRECONDA 
believed that the information was more comprehensive than what is typically offered, given 
the limited time available to decide on immediate reconstruction, and the preferences of some 
surgeons for specific reconstruction options. Furthermore, the only difference between 
women who dropped out and those remaining in the study was their baseline reported social 
support, suggesting that BRECONDA is more appreciated by those lacking an adequate 
support network.  Given the benefits of BRECONDA, it is reassuring that women found the 
website useful and user-friendly, and believed it represented a balanced view of the options 
available. This suggests that women will be inclined to utilize the website once it is made 
widely available. While decisional regret did not differ between groups at 6-months, there 
was a non-significant trend indicating that individuals receiving BRECONDA experienced 
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less regret, with this group now experiencing mild regret
10
. This finding is congruent with the 
concept of decisional regret
32,42
, which typically manifests over the longer term, suggesting 
that as time passes, women who accessed BRECONDA may experience less remorse 
following their reconstruction decision
11
.  This finding is important, given that higher levels 
of decisional regret are associated with greater distress and poorer functional quality of 
life
40,43
.  
 
 While these findings highlight the efficacy of BRECONDA in facilitating 
reconstruction decisions, certain limitations warrant consideration. Although, the 
multicentered nature of this study meant that the breast reconstruction information provided 
to patients was not standardised, the fact that both private and public hospitals were utilised 
for participant recruitment represented a wide range of patients and surgeons. The relatively 
small sample of women recruited from clinics precluded analyses to examine whether the 
intervention effects differed for women eligible for both immediate and delayed 
reconstruction versus delayed reconstruction alone. Future research should address this, to 
ascertain the most suitable timing for this tool to be provided. The dropout rate 
(approximately 27%) in this study was relatively high, although comparable or less than other 
studies assessing the impact of web-based interventions
44
. As women dropping out had a 
greater perceived social support network at baseline, there may have been a self-selection 
bias whereby women perceiving a need for this decisional support participated and remained 
in this study. While participants were recruited nation-wide, the generalizability of these 
findings to non-Australian participants should be addressed in future research. Further, as 
participants were treated at many hospitals, the variability in surgical expertise could not be 
controlled for in analyses. Breast reconstruction rate was relatively low (<20%), although this 
is greater than the national rate (approximately 9-12% )
45
. It was beyond the scope of the 
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current study to assess a number of potential confounding variables, including type and 
timing of reconstruction and radiation therapy. Future research is warranted to investigate 
this. Finally, the follow-up in this study was relatively short; additional research must assess 
the longer-term impact of BRECONDA. This is especially relevant to decisional regret, as the 
aesthetic results of reconstruction are typically not evident for some time after surgery
46
, and 
some may not have completed their final reconstruction surgical procedures at the 6-month 
follow-up. Nonetheless, the finding that women who accessed BRECONDA felt less 
conflicted and more satisfied with the information on which they were making a 
reconstruction decision, and were tending to be less regretful over time, lends support for the 
intervention in facilitating decision-making among women considering reconstruction. The 
next steps are to determine the longer term effects of BRECONDA on a range of medical and 
social outcomes, and to investigate the most efficient and effective means by which to 
translate these findings to the broader clinic setting by making BRECONDA available in 
breast clinics throughout Australia, to ascertain whether these benefits are sustained in the 
longer term. 
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Table 1. BRECONDA Website Content.   
Module Content Description 
Introduction Description of breast reconstruction and who can undergo this 
procedure.  
Making decisions  Overview of the BRECONDA content and the general purpose 
of the website.  
Hints for making a decision Questions women can ask themselves to aid decision-making. 
What reconstruction choices do 
I have? 
Provides reconstruction options, contraindications and 
eligibility criteria.  
When can I have 
reconstruction? 
Immediate versus delayed reconstruction, and factors 
influencing the type and timing of reconstruction offered.  
What to expect How the reconstructed breast will look and feel, reconstruction 
results, and expected recovery time.  
What else should I know before 
making a decision? 
Advantages and disadvantages of reconstruction versus no 
reconstruction and comparison of reconstruction options.  
What might go wrong? Potential complications for reconstruction options.   
My feelings about the 
reconstruction decision/ Tips for 
managing my feelings 
Emotions that may arise during the decision process and 
strategies for recognising and reducing stress.  
Family issues Strategies for communicating with family members about 
reconstruction decisions. 
Other people’s stories Video segments of other women’s experiences of deciding 
whether or not to undergo reconstruction.  
What do I think about Requires the user to indicate the importance of specific values. 
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reconstruction?/What type of 
reconstruction do I prefer? 
Presents a tabular summary, colour coded to reflect the personal 
importance of each value. 
Who to contact for more 
information 
Contact information for healthcare professionals and support 
services. Provides additional websites for further information.  
Conclusion  Reminder to make decisions about reconstruction in 
consultation with a doctor/ healthcare professional. 
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Table 2.  Participant Demographic and Clinical Characteristics at Baseline 
Characteristic Control arm  
(n=106) 
BRECONDA arm 
(n=116) 
 
No. % No. % P-value 
Age (years)     .18 
 Mean 51.88 51.99  
 SD  9.12  9.95  
Country of birth     .12 
 Australia/NZ 92  86.8 90 77.6  
 Western Europe 9 8.5 16 13.8  
 Other 5 4.7 10 8.6  
Marital status     .37 
 Single, never married 7 6.6 14 12.1  
 Married/living with partner 77 72.6 81 69.8  
 Separated/divorced/widowed 22 20.8 21 18.1  
Education     .04 
 Year 10 or less 14 13.2 14 12.1  
 High School Certificate 14 13.2 11 9.5  
 Vocational/TAFE 13 12.3 30 25.9  
 Undergraduate 43 40.6 36 31.0  
 Postgraduate 22 20.7 25 21.5  
Household income     .49 
 Less than $50, 000 29 28.2 33 28.9  
 $50, 001 to $90, 000 30 29.1 32 28.1  
 More than $90, 000 44 42.7 49 43.0  
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Grade of breast cancer     .81 
 DCIS 18 17.0 15 12.9  
 Stage 1 10 9.4 12 10.4  
 Stage 2 34 32.1 37 31.9  
 Stage 3 30 28.3 31 26.7  
 Don’t know 14 13.2 21 18.1  
Time Since Diagnosis (years)      .31 
 Mean 3.10 2.67  
 SD 4.34 3.28  
About to have a mastectomy   .41 
 No 84 80.8 84 76.4  
 Yes 20 19.2 26 23.6  
Mastectomy type      
         Single 84 79.3 89 78.1 .34 
         Double  22 20.7 25 21.9  
Radiation (last month)     .40 
 No 101 95.3 113 97.4  
 Yes 5 4.7 3 2.6  
Chemotherapy (last month)     .91 
 No 100 94.3 109 94.0  
 Yes 6 5.7 7 6.0  
Info. from breast/plastic surgeon     .54 
 Neither 50 46.3 55 47.9  
 Breast or plastic surgeon 36 33.3 45 38.7  
 Breast and plastic surgeon 20 20.4 16 13.4  
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Social Support Satisfaction     .28 
Mean 5.04 5.01  
SD .93 .82  
Social Support Number     .51 
Mean 5.72 5.49  
SD 3.50 3.96  
Abbreviation: Radiation (last month) = Radiation treatment in last month; Chemotherapy 
(last month) = Chemotherapy treatment in last month; Info from breast/plastic surgeon = 
Received information from breast and/or plastic surgeon.  
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Table 3. Summary Results of  Follow-Up Planned Contrasts 
 
 
 BRECONDA (n = 116) Control (n = 106)    
Primary Outcome Mean SE Mean SE Adjusted P Cohen’s d Possible range 
      
Decisional conflict       
 1-month 27.18 2.31 35.50 2.46 .005 .35 0-100 
         
 BRECONDA (n = 116) Control (n = 106)    
Secondary Outcome Mean SE Mean SE P Cohen’s d Possible range 
 
Decisional Conflict  
       
 
 6-month 24.13 2.39 31.43 2.50 .016 .29 0-100 
Satisfaction with 
Information  
       
 1-month 3.71 .11 3.39 .12 .016 .31 1-5 
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 6-month 3.85 .12 3.54 .12 .028 .27 1-5 
Decision Regret        
 6-month 21.39 2.29 25.75 2.39 .065 .21 0-164 
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Figure Legends 
 
Figure 1. CONSORT Diagram 
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Figure 2. BRECONDA Main Menu 
  
26 
 
Figure 3. “My Feelings about Reconstruction” section of BRECONDA 
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Figure 4.  “Other People’s Stories” section of BRECONDA 
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Figure 5. Change over time for Decisional Conflict by Condition 
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Figure 6. Change over time for Satisfaction with Information by Condition 
